Back
Guidewire Software, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
57
GWRE
Guidewire Software, Inc.
Last Price:
$198.33
Seasonality Move:
4.07%
Sell
29
NONOF
Novo Nordisk A/S
Last Price:
$47.30
Seasonality Move:
5.38%
Buy
57
Guidewire Software, Inc. (GWRE)
is a Buy
Is Guidewire Software, Inc. a Buy, Sell or Hold?
-
The current Guidewire Software, Inc. [GWRE] share price is $210.55. The Score for GWRE is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
GWRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $48.84. The Score for NONOF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GWRE Stock Price Chart
What is Guidewire Software, Inc.'s stock price today?
-
The Guidewire Software, Inc. share price today is $210.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GWRE is experiencing slight selling pressure.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $48.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.
GWRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.89 | Sell |
| Relative Strength Index (14 RSI): | 36.99 | Sell |
| Chaikin Money Flow: | -154038 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (211.66 - 222.44) | Sell |
| Bollinger Bands (100): | (213.42 - 242.58) | Sell |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.95 | Sell |
| Relative Strength Index (14 RSI): | 49.74 | Sell |
| Chaikin Money Flow: | 18686 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.62 - 48.9) | Buy |
| Bollinger Bands (100): | (48.25 - 59.99) | Sell |
GWRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 213.54 | Sell |
| 20-day SMA: | 215.31 | Sell |
| 50-day SMA: | 228.59 | Sell |
| 200-day SMA: | 218.84 | Sell |
| 8-day EMA: | 213.14 | Sell |
| 20-day EMA: | 217.01 | Sell |
| 50-day EMA: | 224.17 | Sell |
| 200-day EMA: | 216.79 | Sell |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.78 | Buy |
| 20-day SMA: | 47.6 | Buy |
| 50-day SMA: | 51.93 | Sell |
| 200-day SMA: | 62.79 | Sell |
| 8-day EMA: | 47.88 | Buy |
| 20-day EMA: | 48.31 | Buy |
| 50-day EMA: | 50.96 | Sell |
| 200-day EMA: | 64.53 | Sell |
Guidewire Software, Inc. Earnings Growth & GWRE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.11 per share, an increase this year of $1.12 per share, and an increase next year of $0.58 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Guidewire Software, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||